These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36028513)

  • 1. Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD.
    Rosso A; Egervall K; Elmståhl S
    NPJ Prim Care Respir Med; 2022 Aug; 32(1):30. PubMed ID: 36028513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic obstructive pulmonary disease in independent community-dwelling older adults: The Fujiwara-kyo study.
    Yoshikawa M; Yamamoto Y; Tomoda K; Fujita Y; Yamauchi M; Osa T; Uyama H; Okamoto N; Kurumatani N; Kimura H
    Geriatr Gerontol Int; 2017 Dec; 17(12):2421-2426. PubMed ID: 28620960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease.
    Jo YS; Moon JY; Park YB; Kim YH; Um SJ; Kim WJ; Yoon HK; Yoo KH; Jung KS; Rhee CK
    BMC Pulm Med; 2022 Mar; 22(1):91. PubMed ID: 35296272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease.
    Güder G; Brenner S; Störk S; Held M; Broekhuizen BD; Lammers JW; Hoes AW; Rutten FH
    BMC Pulm Med; 2015 Jul; 15():83. PubMed ID: 26228243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. People with COPD have greater participation restrictions than age-matched older adults without respiratory conditions assessed during the COVID-19 pandemic.
    O'Hoski S; Kuspinar A; Wald J; Richardson J; Goldstein R; Beauchamp MK
    PLoS One; 2022; 17(10):e0275264. PubMed ID: 36194605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontitis Is Associated with Chronic Obstructive Pulmonary Disease.
    Takeuchi K; Matsumoto K; Furuta M; Fukuyama S; Takeshita T; Ogata H; Suma S; Shibata Y; Shimazaki Y; Hata J; Ninomiya T; Nakanishi Y; Inoue H; Yamashita Y
    J Dent Res; 2019 May; 98(5):534-540. PubMed ID: 30848974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced ambient PM
    Bo Y; Chang LY; Guo C; Lin C; Lau AKH; Tam T; Lao XQ
    Environ Int; 2021 Nov; 156():106706. PubMed ID: 34153892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
    Chen W; Sadatsafavi M; FitzGerald JM; Lynd LD; Sin DD
    Respir Res; 2021 Feb; 22(1):59. PubMed ID: 33602241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
    Sanchez-Salcedo P; Divo M; Casanova C; Pinto-Plata V; de-Torres JP; Cote C; Cabrera C; Zagaceta J; Rodriguez-Roisin R; Zulueta JJ; Marin JM; Celli B
    Eur Respir J; 2014 Aug; 44(2):324-31. PubMed ID: 24696115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related annual decline of lung function in patients with COPD.
    Kim SJ; Lee J; Park YS; Lee CH; Yoon HI; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():51-60. PubMed ID: 26766907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment and application effect appraisement of community chronic obstructive pulmonary disease integrated management system].
    Zhao DX; Chen SY; Zhou YM; Li XC; Zou WF; Chen XM; Ran PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):102-107. PubMed ID: 28209040
    [No Abstract]   [Full Text] [Related]  

  • 15. Rate of Forced Expiratory Volume in One Second and Forced Expiratory Volume in One Second/Forced Vital Capacity Decline among Indonesian Patients with Chronic Obstructive Pulmonary Disease after a Year of Treatment.
    Ariawan WP; Yunus F; Damayanti T; Nurwidya F
    Int J Appl Basic Med Res; 2019; 9(2):95-99. PubMed ID: 31041172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.
    Bui DS; Lodge CJ; Burgess JA; Lowe AJ; Perret J; Bui MQ; Bowatte G; Gurrin L; Johns DP; Thompson BR; Hamilton GS; Frith PA; James AL; Thomas PS; Jarvis D; Svanes C; Russell M; Morrison SC; Feather I; Allen KJ; Wood-Baker R; Hopper J; Giles GG; Abramson MJ; Walters EH; Matheson MC; Dharmage SC
    Lancet Respir Med; 2018 Jul; 6(7):535-544. PubMed ID: 29628376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 19. COPD patients with exertional desaturation are at a higher risk of rapid decline in lung function.
    Kim C; Park YB; Park SY; Park S; Kim CH; Park SM; Lee MG; Hyun IG; Jung KS; Kim DG
    Yonsei Med J; 2014 May; 55(3):732-8. PubMed ID: 24719141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.